CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 185 filers reported holding CYTOKINETICS INC in Q4 2020. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,545,924 | +9.5% | 425,863 | +21.3% | 0.03% | +17.4% |
| Q2 2023 | $11,455,133 | -7.3% | 351,169 | 0.0% | 0.02% | -14.8% |
| Q1 2023 | $12,357,637 | -21.3% | 351,169 | +2.5% | 0.03% | -22.9% |
| Q4 2022 | $15,705,675 | +14.4% | 342,769 | +21.0% | 0.04% | +2.9% |
| Q3 2022 | $13,729,000 | +47.0% | 283,369 | +19.2% | 0.03% | +54.5% |
| Q2 2022 | $9,342,000 | +51.2% | 237,769 | +41.6% | 0.02% | +69.2% |
| Q1 2022 | $6,179,000 | -14.1% | 167,865 | +6.3% | 0.01% | -7.1% |
| Q4 2021 | $7,197,000 | +1.4% | 157,905 | -20.5% | 0.01% | -6.7% |
| Q3 2021 | $7,096,000 | +77.0% | 198,555 | -2.0% | 0.02% | +87.5% |
| Q2 2021 | $4,009,000 | +4.1% | 202,555 | +22.4% | 0.01% | 0.0% |
| Q1 2021 | $3,851,000 | +149.1% | 165,545 | +122.5% | 0.01% | +100.0% |
| Q4 2020 | $1,546,000 | -42.1% | 74,400 | -39.7% | 0.00% | -42.9% |
| Q3 2020 | $2,672,000 | +52.3% | 123,422 | +65.9% | 0.01% | +40.0% |
| Q2 2020 | $1,754,000 | +100.0% | 74,400 | 0.0% | 0.01% | +66.7% |
| Q1 2020 | $877,000 | +25.5% | 74,400 | +12.9% | 0.00% | +50.0% |
| Q4 2019 | $699,000 | – | 65,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |